Index
By TNW
About Index
Trending news
Analyze
Pricing
Sign up or sign in
Novartis Venture Fund
Work at Novartis Venture Fund?
Add yourself to this profile
0
Novartis Venture Fund
Edit Profile
nvfund.com
B2b
More info
Elsewhere
Alexa global traffic share
Overview
Investments
41
Portfolio
Add info
All markets
Biotechnology (22)
Health Care (4)
Pharmaceuticals (3)
Health Diagnostics (2)
Medical (2)
Maps (1)
Life Sciences (1)
Therapeutics (1)
Mobile (1)
All countries
United States (18)
United Kingdom (3)
Switzerland (1)
All company sizes
1-10 (2)
11-50 (9)
51-200 (2)
201-500 (1)
BioNano Genomics
Maps +1
Total funding
$102.1M in
6 rounds
from 13 investors
By Novartis Venture Fund
$53M Series C in Nov, 2014
Atlas Genetics
Biotechnology +1
Total funding
$110.4M in
4 rounds
from 25 investors
By Novartis Venture Fund
$35M Series D in Jan, 2017
Vaxin Inc.
United States
Total funding
$16M in
1 rounds
from 4 investors
By Novartis Venture Fund
$16M Venture capital in Feb, 2015
Merganser Biotech, Inc.
Biotechnology
Total funding
$28M in
1 rounds
from 5 investors
By Novartis Venture Fund
$28M Series A in Feb, 2015
Pulmatrix
Biotechnology
Total funding
$43.7M in
3 rounds
from 11 investors
By Novartis Venture Fund
$30.2M Series B in Nov, 2009
Seventh Sense Biosystems
Biotechnology
Total funding
$41.8M in
6 rounds
from 13 investors
By Novartis Venture Fund
$16M Series B in Aug, 2014
Proteostasis Therapeutics, Inc.
Biotechnology
Total funding
$73.6M in
2 rounds
from 6 investors
By Novartis Venture Fund
$70.6M Series A in Aug, 2008
Alios BioPharma
Biotechnology
Total funding
$49M in
2 rounds
from 7 investors
By Novartis Venture Fund
$41M Series B in Apr, 2014
NovImmune
Biotechnology
Total funding
$137.2M in
4 rounds
from 15 investors
By Novartis Venture Fund
$54.8M Series C in May, 2009
Catalyst Biosciences
Biotechnology
Total funding
$96.7M in
6 rounds
from 26 investors
By Novartis Venture Fund
$5.1M Venture capital in Apr, 2013
Effector Therapeutics
Biotechnology
Total funding
$45M in
1 rounds
from 7 investors
By Novartis Venture Fund
$45M Venture capital in May, 2013
Akebia Therapeutics
Health Care +1
Total funding
$61.1M in
3 rounds
from 21 investors
By Novartis Venture Fund
$41M Series C in Jun, 2013
Trellis Bioscience
Biotechnology
Total funding
$10M in
1 rounds
from 4 investors
By Novartis Venture Fund
$10M Series B in Feb, 2007
Visiogen
Health Care
Total funding
$40M in
1 rounds
from 7 investors
By Novartis Venture Fund
$40M Series D in May, 2009
Exit
Abbott
, Sep 3, 2009
Immune Targeting Systems
Biotechnology
Total funding
$13.2M in
1 rounds
from 4 investors
By Novartis Venture Fund
$13.2M Series A in Mar, 2010
Exit
Vaxin Inc.
, Feb 17, 2015
Advanced Animal Diagnostics
Biotechnology
Total funding
$27.7M in
3 rounds
from 5 investors
By Novartis Venture Fund
$11M Series B in Mar, 2011
ImaginAb
Biotechnology +1
Total funding
$38.8M in
3 rounds
from 8 investors
By Novartis Venture Fund
$21M Series B in May, 2014
ROX Medical
Health Care
Total funding
$46M in
2 rounds
from 6 investors
By Novartis Venture Fund
$40M Series E in Sep, 2016
FORMA Therapeutics
Biotechnology
Total funding
$29.5M in
2 rounds
from 4 investors
By Novartis Venture Fund
$25.5M Series B in Dec, 2009
Quartet Medicine
Biotechnology
Total funding
$17M in
1 rounds
from 3 investors
By Novartis Venture Fund
$17M Series A in Oct, 2014
Aerie Pharmaceuticals
Biotechnology +1
Total funding
$331.4M in
4 rounds
from 9 investors
By Novartis Venture Fund
$40M Undisclosed in Mar, 2017
Adicet Bio
Biotechnology
Total funding
$51M in
1 rounds
from 3 investors
By Novartis Venture Fund
$51M Series A in Jan, 2016
F2G
Medical +2
Total funding
$60M in
1 rounds
from 8 investors
By Novartis Venture Fund
$60M Venture Capital in Jun, 2016
Annexon Biosciences
Biotechnology +2
Total funding
$44M in
1 rounds
from 5 investors
By Novartis Venture Fund
$44M Series B in Jun, 2016
Lemonaid Health
Mobile +1
Total funding
$12.7M in
2 rounds
from 8 investors
By Novartis Venture Fund
$11M Series A in May, 2017
Cavion
Health Care +1
Total funding
$31.1M in
3 rounds
from 5 investors
By Novartis Venture Fund
$26.1M Series A in Jan, 2017
Bicycle Therapeutics
Biotechnology
Total funding
$89.3M in
3 rounds
from 9 investors
By Novartis Venture Fund
£40M Series B in Jun, 2017
Want to see the complete list?
Go Pro!
